NCT01978080
Completed
N/A
ETSense: Adaptive Portable Essential Tremor Monitor - Symptomatic Impact Study
ConditionsEssential Tremor
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Essential Tremor
- Sponsor
- Great Lakes NeuroTechnologies Inc.
- Enrollment
- 39
- Locations
- 2
- Primary Endpoint
- Clinical Global Impression-Change Scale score
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
The specific aim of this study is to evaluate if tremor severity and quality of life can be improved more using continuous home monitoring along with traditional assessments versus traditional assessments alone.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosed with essential tremor
- •Currently taking medication to control tremor
Exclusion Criteria
- •Cognitive limitations that prevent comprehension or execution of study protocol
Outcomes
Primary Outcomes
Clinical Global Impression-Change Scale score
Time Frame: End of Month 1, End of Month 2, End of Month 3
Utilized to measure any improvement or worsening of symptoms relative to a baseline state at enrollment
Secondary Outcomes
- Clinical Global Impression-Severity Scale Score(Enrollment, End of Month 1, End of Month 2, End of Month 3)
- Washington Heights Inwood Genetic Study of Essential Tremor (WHIGET) Tremor Rating Scale(Enrollment, End of Month 1, End of Month 2, End of Month 3)
- Quality of Life in Essential Tremor Questionnaire(Enrollment, End of Month 1, End of Month 2, End of Month 3)
Study Sites (2)
Loading locations...
Similar Trials
Completed
N/A
Adaptive Portable Essential Tremor MonitorEssential TremorNCT01602042Great Lakes NeuroTechnologies Inc.20
Completed
N/A
Assessment of Tremor Using SNUMAP Motion Sensing SystemTremorNCT01731145Seoul National University Hospital187
Completed
N/A
Upper Limb Tremor Reduction in Essential Tremor PatientsEssential TremorNCT06343285Encora, Inc.71
Terminated
N/A
Transcranial Stimulation for Essential TremorEssential TremorNCT03025529Beth Israel Deaconess Medical Center8
Completed
Phase 2
Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential TremorEssential TremorNCT00102596National Institute of Neurological Disorders and Stroke (NINDS)21